PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 7 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Kava extract preparations have been used for these indications [PMID: 33189846].
Evidence for the efficacy of kava for treating anxiety has been affirmed through clinical trials and meta-analyses [PMID: 26527536].
Kava and kava extracts have shown potential to help alleviate pain [PMID: 30710733].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33189846 (2021) — Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. · Journal of ethnopharmacology
- 2.PMID: 21442674 (2011) — Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. · Phytotherapy research : PTR
- 3.PMID: 30710733 (2019) — Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum). · Journal of ethnopharmacology
- 4.PMID: 21112196 (2011) — Kava hepatotoxicity solution: A six-point plan for new kava standardization. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 22585547